Prelude Therapeutics | 8-K/A: Current report (Amendment)
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lim Bryant David
Prelude Therapeutics | EFFECT: Others
Prelude Therapeutics | 10-Q: Quarterly report
Prelude Therapeutics | 8-K: Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Prelude Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Prelude Therapeutics | DEF 14A: Definitive information statements
Prelude Therapeutics | ARS: Annual Report to Security Holders
Prelude Therapeutics | DEFA14A: Others
Prelude Therapeutics | 8-K: Current report
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huang Jane
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Scherle Peggy
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lim Bryant David
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chardonnet Laurent
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Combs Andrew
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huang Jane
Prelude Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vaddi Krishna
Prelude Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Prelude Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Prelude Therapeutics | 10-K: Annual report
No Data